Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLCRelease Date:Quality Improvement, Research Oncology Italy Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA 2025 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Research on Diagnostic and Treatment of Invasive Mold DiseaseRelease Date:Research Hospital China Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC)Release Date:Education Oncology Spain Addressing Barriers to Cancer Care for AIAN and NHPI IndividualsQuality Improvement Oncology USA Research on Disease Burden of CRE (including non-MBL and MBL-CRE), CR-PA and Stenotrophomonas Maltophilia in ChinaRelease Date:Research Hospital China Educational approaches to address immunization practice gaps and improve adult vaccination coverage in SwitzerlandRelease Date:Education Vaccines Switzerland China Medical Education in Non-small Cell Lung Cancer Diagnosis, Treatment and Long-Term Disease ManagementRelease Date:Education Oncology China Title Grant Type Focus Area Country Application Due Date Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disordersRelease Date:Education Rare Disease Japan Long-acting Growth Hormone ResearchRelease Date:Research Rare Disease All COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)Release Date:Quality Improvement Oncology All 2020 Osteoarthritis and Osteoarthritis Pain- Virtual LearningEducation Internal Medicine All NASH – Future of Non-invasive Diagnosis TechnologiesRelease Date:Education Internal Medicine All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse NavigatorRelease Date:Quality Improvement Rare Disease USA Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)Release Date:Partner:International Society for Infectious Diseases (ISID)
Quality Improvement Hospital All Advances in Oncology Therapy in Renal Cell CarcinomaRelease Date:Education Oncology Japan Increasing Awareness of Nuclear Scintigraphy in Cardiac AmyloidosisRelease Date:Education Rare Disease All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China RegionRelease Date:Partner:RCNi (subsidiary of the Royal College of Nursing)
Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease Argentina, Brazil, Chile, Colombia Vaccine Preventable Diseases – COVID-19 (closed early)Release Date:Research Vaccines All